HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J Appl Physiol 105: 417-419, 2008. First published June 26, 2008; doi:10.1152/japplphysiol.90529.2008
8750-7587/08 $8.00

This Article Free upon publication Full Text Free Full Text (PDF) Free All Versions of this Article: 105/2/417    most recent 90529.2008v1 Submit a response View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Lundby, C. Articles by Robach, P. Search for Related Content PubMed PubMed Citation Articles by Lundby, C. Articles by Robach, P.

Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing

Copenhagen Muscle Research Centre, Rigshospitalet, Blegdamsvej, Copenhagen, Denmark

Submitted 16 April 2008 ; accepted in final form 11 June 2008

Background: the main action of recombinant human erythropoietin (rHuEpo) is to increase the oxygen carrying capacity of the blood. To prevent a possible misuse of rHuEpo, this is tested in urine samples collected from athletes by World Anti-Doping Agency (WADA)-accredited laboratories. Recently the test has met serious critiques, and the aims of the present study were to investigate the detection power of the test as well as the variability in the test power comparing the results of two WADA-accredited laboratories. Methods: eight human subjects were studied for 7 wk and treated with rHuEpo for 4 wk with 2 wk of "boosting" followed by 2 wk of "maintenance" and a post period of 3 wk. Urine samples were obtained during all periods. Results: laboratory A determined rHuEpo misuse in all subjects during the boosting period, whereas laboratory B found no misuse, with one sample to be negative, and the remaining seven to be suspicious. The detection rates decreased throughout the maintenance and post period when total hemoglobin mass and exercise performance were elevated. During this period, laboratory A found only two of 24 samples to be positive and three to be suspicious, and laboratory B found no positive or suspicious samples. Conclusion: this study demonstrates a poor agreement in test results comparing two WADA-accredited laboratories. Moreover, after the initial rHuEpo boosting period the power to detect rHuEpo misuse during the maintenance and post periods appears minimal.

doping; detection; exercise

This article has been cited by other articles:

				P. Robach, S. Recalcati, D. Girelli, C. Gelfi, N. J. Aachmann-Andersen, J. J. Thomsen, A. M. Norgaard, A. Alberghini, N. Campostrini, A. Castagna, et al. Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin Blood, June 25, 2009; 113(26): 6707 - 6715. [Abstract] [Full Text] [PDF]

				G. Lippi, G. Banfi, J. Morkeberg, B. Belhage, R. Damsgaard, and V. Skibeli Comments on Delanghe and Joyner's editorial "testing for recombinant human erythropoietin". J Appl Physiol, December 1, 2008; 105(6): 1990 - 1991. [Full Text] [PDF]

				G. Lippi, W. E. Jelkmann, G. L. Salvagno, G. C. Guidi, C. R. Valeri, G. Ragno, B. Kayser, F. Lasne, Y. O. Schumacher, T. Pottgiesser, et al. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing". Problems associated with current anti-doping testing: is quality assessment a reliable solution? J Appl Physiol, December 1, 2008; 105(6): 1992 - 1993. [Full Text] [PDF]

				C. Lundby Reply to Lippi et al.'s "Comments on 'Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing' " J Appl Physiol, December 1, 2008; 105(6): 1997 - 1998. [Full Text] [PDF]

				J. R. Delanghe and M. J. Joyner Testing for recombinant human erythropoietin J Appl Physiol, August 1, 2008; 105(2): 395 - 396. [Full Text] [PDF]